2/24/2026CDE Releases Q&A Document on Development Safety Update Reports

2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...

2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...

2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis

2/24/2026Ascentage Registers U.S. Phase 1 Trial for BTK PROTAC APG-3288

2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...

2/24/2026Frontier Biotech Inks Global siRNA Licensing Deal with GSK

2/24/2026XtalPi and YolTech Forge AI Alliance to Advance mRNA and In Vivo CAR-T...

2/24/2026United Labs and Novo Nordisk Post Strong Phase 2 Data for UBT251 Tripl...

2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy

2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought

2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer

2/20/2026CSPC's Long-Acting SYH2082 Clears FDA to Begin Clinical Trials

2/16/2026CSPC's Long-Acting Ropivacaine Injection Cleared for Clinical Trials i...

2/16/2026FindCure Secures CNY 100M+ Series B to Accelerate Cancer Therapy Progr...

2/16/2026CStone's Trispecific Antibody CS2009 Receives FDA IND Clearance, Ente...

2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...

2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application

2/13/2026ProteLight Pharmaceuticals Files Hong Kong IPO application

2/13/2026VivaVision Files Hong Kong IPO to Fund Late-Stage Ophthalmology Progra...

2/13/2026Salubris Files Hong Kong IPO to Expand Cardiovascular-Kidney-Metabolic...

2/13/2026Pentagon Reverses Decision After Briefly Listing WuXi AppTec as Chines...

2/13/2026Gilead Acquires Global Rights to Genhouse Oral Cancer Drug With $80 Mi...

2/12/2026CDE Issues Draft Pharmaceutical Guidance for Rare Disease Chemical Dru...

2/12/2026Ascletis Picks Oral Amylin Agonist ASC36 for Obesity Development, Plan...

2/12/2026RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials

2/12/2026Lilly's Jaypirca Approved in China for Previously Treated CLL and SLL ...

2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy

2/12/2026UniXell Raises Over CNY 50M in Series A+ to Advance Stem Cell Therapy ...

2/12/2026China Indicts AstraZeneca and Former China Head Leon Wang Over Data an...

Page:9/61 Total number of articles:1829: [First][<<] [7] [8] [9] [10] [11] [>>] [End]